2 Pharmacotherapy in obesity and BED: a difficult legacy Pharmacological treatment of obesity has historically faced significant limitations, with many agents demonstrating only moderate efficacy and a high incidence of adverse effects [24, 25]
Our patients often find that taking charge of their eating habits is the most encouraging part of their treatment
It suppresses appetite through GLP-1 receptor activation in the hypothalamus
Following a structured dosing schedule, monitoring side effects, and using telehealth support like Doctronic.ai can help maximize benefits while maintaining safety in 2026 and beyond.
Side effects reported in clinical trials are described by the company as similar to those observed with injectable formats, including nausea, diarrhea, and vomiting
Characterising GH-specific skeletal anabolic responses in the absence of glucocorticoid-mediated bone resorption confounds introduced by non-selective GH secretagogue cortisol co-secretion